MDT · News · 20260917N
Guidance / Outlook
Medtronic plc · 2026-09-17 · Importance 73 · Surprise 76 · In source text
Medtronic raised its fiscal 2027 revenue and profit outlook for the second time on September 17, 2026. First-quarter revenue was $9.76 billion and adjusted earnings per share was $1.45, both above analyst expectations. Double-digit growth was reported across all major business segments, supported by strong cardiovascular-device demand, new partnerships, and product launches. Tariff headwinds and uncertainty over a potential diabetes-business separation remain challenges to the outlook.
Key facts
- Medtronic has raised its fiscal 2027 profit and revenue outlook for the second time. source
- Medtronic reported first-quarter revenue of $9.76 billion. source
- Medtronic said the guidance raise was driven by strong demand for cardiovascular devices and double-digit growth across all major business segments. source
- Medtronic faces challenges including tariff headwinds and uncertainty surrounding the potential separation of its diabetes business. source
- Medtronic said the first-quarter revenue of $9.76 billion and adjusted EPS of $1.45 both exceeded analyst expectations. source
- Medtronic reported adjusted earnings per share of $1.45 for the first quarter. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | Medtronic has raised its fiscal 2027 profit and revenue outlook for the second time. |
| net_income | positive | probable | — | Medtronic has raised its fiscal 2027 profit and revenue outlook for the second time. |
| revenue | positive | realized | — | Medtronic reported first-quarter revenue of $9.76 billion. |